Mante M - Search Results

1

Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).

Rockenstein E, Mallory M, Mante M, Sisk A, Masliaha E. Rockenstein E, et al. Among authors: mante m. J Neurosci Res. 2001 Nov 15;66(4):573-82. doi: 10.1002/jnr.1247. J Neurosci Res. 2001. PMID: 11746377

2

Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE.

Masliah E, Samuel W, Veinbergs I, Mallory M, Mante M, Saitoh T. Masliah E, et al. Among authors: mante m. Brain Res. 1997 Mar 21;751(2):307-14. doi: 10.1016/s0006-8993(96)01420-5. Brain Res. 1997. PMID: 9099820

3

Differential neurotrophic effects of apolipoprotein E in aged transgenic mice.

Veinbergs I, Mallory M, Mante M, Rockenstein E, Gilbert JR, Masliah E. Veinbergs I, et al. Among authors: mante m. Neurosci Lett. 1999 Apr 23;265(3):218-22. doi: 10.1016/s0304-3940(99)00243-8. Neurosci Lett. 1999. PMID: 10327170

4

Neurotrophic effects of Cerebrolysin in animal models of excitotoxicity.

Veinbergs I, Mante M, Mallory M, Masliah E. Veinbergs I, et al. Among authors: mante m. J Neural Transm Suppl. 2000;59:273-80. doi: 10.1007/978-3-7091-6781-6_29. J Neural Transm Suppl. 2000. PMID: 10961439

5

beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor.

Hashimoto M, Rockenstein E, Mante M, Mallory M, Masliah E. Hashimoto M, et al. Among authors: mante m. Neuron. 2001 Oct 25;32(2):213-23. doi: 10.1016/s0896-6273(01)00462-7. Neuron. 2001. PMID: 11683992 Free article.

6

Effects of Cerebrolysin on amyloid-beta deposition in a transgenic model of Alzheimer's disease.

Rockenstein E, Mallory M, Mante M, Alford M, Windisch M, Moessler H, Masliah E. Rockenstein E, et al. Among authors: mante m. J Neural Transm Suppl. 2002;(62):327-36. J Neural Transm Suppl. 2002. PMID: 12456076

7

The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.

Rockenstein E, Adame A, Mante M, Moessler H, Windisch M, Masliah E. Rockenstein E, et al. Among authors: mante m. J Neural Transm (Vienna). 2003 Nov;110(11):1313-27. doi: 10.1007/s00702-003-0025-7. J Neural Transm (Vienna). 2003. PMID: 14628195

8

An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model.

Hashimoto M, Rockenstein E, Mante M, Crews L, Bar-On P, Gage FH, Marr R, Masliah E. Hashimoto M, et al. Among authors: mante m. Gene Ther. 2004 Dec;11(23):1713-23. doi: 10.1038/sj.gt.3302349. Gene Ther. 2004. PMID: 15483670

9

Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound cerebrolysin.

Rockenstein E, Adame A, Mante M, Larrea G, Crews L, Windisch M, Moessler H, Masliah E. Rockenstein E, et al. Among authors: mante m. J Neural Transm (Vienna). 2005 Feb;112(2):269-82. doi: 10.1007/s00702-004-0181-4. Epub 2004 Jul 7. J Neural Transm (Vienna). 2005. PMID: 15657642

10

Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein.

Rockenstein E, Schwach G, Ingolic E, Adame A, Crews L, Mante M, Pfragner R, Schreiner E, Windisch M, Masliah E. Rockenstein E, et al. Among authors: mante m. J Neurosci Res. 2005 Apr 15;80(2):247-59. doi: 10.1002/jnr.20446. J Neurosci Res. 2005. PMID: 15765523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters